Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent years and can now share intelligence on some significant breakthroughs in the key markets of Brazil and...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
Standards and best practices to support trace metal quantitation in cell culture chemically defined media and hydrolysates
In March, Dr Bala Ramanathan, Senior Scientist at Janssen presented the latest views, standards and best practices to...
BioPhorum accelerates growth
We are delighted that BioPhorum has been ranked in the fourth annual list of FT 1000 Europe’s Fastest Growing Compani...
Maintaining the biologics supply chain in challenging times
As we all adjust to the progressive impact of Covid-19, one consequence has been an increased focus on the biologics sup...
As Ask BPOG morphs into Ask BioPhorum, are you asking enough questions of the community?
Since 2013, Ask BPOG has become a great asset for the industry, with more than 3,000 questions being posted and 11,000 r...
BioPhorum’s Maturity Assessment Tool gains momentum
Supplier relationship management is one of the most crucial aspects of biopharmaceutical manufacturing and affects every...
Supply chain, forecasting and demand planning solutions gain momentum
The relationship between suppliers and manufacturers is one of the most crucial in biopharmaceutical manufacturing. This...
BioPhorum and Rx-360 pilot a joint audit model for single-use systems
BioPhorum and Rx-360 have agreed a pilot to validate the use of the Joint Audit Model in the single-use systems supply c...
Key updates to Brazilian post-approval change requirements and use of Polysorbate 80 in China
The BioPhorum Post-Approval Strategy Team has been working hard in international regulatory environments over recent yea...
MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, repre...
Standards and best practices to support trace metal quantitation in cell culture chemically defined media and hydrolysates
In March, Dr Bala Ramanathan, Senior Scientist at Janssen presented the latest views, standards and best practices to...
BioPhorum accelerates growth
We are delighted that BioPhorum has been ranked in the fourth annual list of FT 1000 Europe’s Fastest Growing Compani...
Maintaining the biologics supply chain in challenging times
As we all adjust to the progressive impact of Covid-19, one consequence has been an increased focus on the biologics sup...
As Ask BPOG morphs into Ask BioPhorum, are you asking enough questions of the community?
Since 2013, Ask BPOG has become a great asset for the industry, with more than 3,000 questions being posted and 11,000 r...
BioPhorum’s Maturity Assessment Tool gains momentum
Supplier relationship management is one of the most crucial aspects of biopharmaceutical manufacturing and affects every...
Supply chain, forecasting and demand planning solutions gain momentum
The relationship between suppliers and manufacturers is one of the most crucial in biopharmaceutical manufacturing. This...
BioPhorum and Rx-360 pilot a joint audit model for single-use systems
BioPhorum and Rx-360 have agreed a pilot to validate the use of the Joint Audit Model in the single-use systems supply c...
